Mechanisms of Exposure Therapy for OCD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorMclean Hospital

About this trial

Exposure therapy is the most effective treatment available for obsessive compulsive disorder, yet up to 50% of patients do not recover because the mechanisms underlying successful response are poorly understood, leading to significant variability in how clinicians conduct exposure therapy. The main purpose of this study is to determine which target mechanisms are most critical to engage in real-world exposure sessions to produce good treatment outcomes. Adult participants (N = 400) with Obsessive Compulsive Disorder (OCD) receiving exposure therapy from two sites (McLean Hospital, San Diego State University) across the continuum of care (outpatient, partial hospital, residential) will complete baseline clinical and demographic measures as well as weekly symptom reports. The project will measure exposure mechanisms across three levels of analysis (self-report, observer-rated behavior, physiology) during each exposure session. Mechanisms assessed will include a broad range of variables based on both habituation and inhibitory learning models of exposure. Self-report and observer-rated mechanisms will be measured with the Exposure Feedback Form, created and piloted by the study team. Physiological mechanisms will include skin conductance response, heart rate, and heart rate variability measured with a wristwatch. The current study will determine (1) which exposure mechanisms lead to favorable clinical outcomes, and (2) what makes a good exposure for whom. Results of this study have the potential to improve personalized care for the many patients who do not remit following exposure therapy for OCD.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Between the ages of 18-65 years old

Seeking exposure treatment at McLean Hospital OCD Institute or San Diego State University

Have a diagnosis of OCD

Able to complete study measures and treatment procedures in English

Disqualifiers

Acute symptoms of psychosis

Active suicidality (plan, means, intent and/or suicide attempt in past 3 months)

Presence of co-occurring symptoms that warrant higher level of care (e.g., inpatient treatment)

Presence of any medical, psychiatric, or developmental condition that would prevent patients from completing assessments or exposure exercises (e.g., non-verbal autism spectrum disorder)

Trial design

Design model

Single group

Treatments tested in this trial

  • Exposure therapy

    Behavioral

    Participants will complete exposure therapy for up to 12 weeks, and coached exposure session will be approximately 50 minutes.

Treatment groups

400 Participants
are divided into 1 treatment group
Group A: Exposure therapyExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Yale-Brown Obsessive Compulsive Scale (YBOCS)

The YBOCS is a 10 self-report measure of OCD severity.

Time frame
Up to 12 weeks

Secondary outcomes

1

Quality of Life Enjoyment & Satisfaction Questionnaire (QLES)

The QLES is a 14-item self-report measure assesses the degree of enjoyment and satisfaction experienced in various daily functioning domains.

Time frame
Up to 12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.